Opendata, web and dolomites

PrevictDrugs SIGNED

Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PrevictDrugs project word cloud

Explore the words cloud of the PrevictDrugs project. It provides you a very rough idea of what is the project "PrevictDrugs" about.

nearly    instant    daily    combine    hazard    validating    communication    ing    cameras    efficiency    gaining    drive    monitoring    caregivers    treatments    addiction    screenings    therapy    record    disruptive    digitalisation    tools    voluntary    asked    suffering    device    convenience    eyes    module    care    iot    add    efficient    abuse    personalised    settings    acceptance    innovative    alcohol    personal    suffer    interventions    drug    ab    global    previct    correct    sophisticated    portal    designed    reactive    pupillometry    gambling    continuous    fast    time    drugs    outcomes    prioritisation    ai    platform    app    proactive    instantly    medical    addictive    transform    cravings    complete    unbound    smartphone    distance    million    eye    pupil    healthcare    yield    kontigo    extreme    illicit    patients    privacy    pharmacodynamically    market    solution    cloud    reactions    mood    commercialisation    relapse    instead    video    patient    worldwide    internet    disorders    sobriety    biomarkers    constitute    self    place    routes    clinical    ehealth    prepare    risks    thing   

Project "PrevictDrugs" data sheet

The following table provides information about the project.

Coordinator
KONTIGO CARE AB 

Organization address
address: PAVEL SNICKARES GRAND 12
city: UPPSALA
postcode: 753 20
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KONTIGO CARE AB SE (UPPSALA) coordinator 50˙000.00

Map

 Project objective

Drug addiction is a global problem; nearly 30 million illicit drug users worldwide suffer from problematic drug use. Kontigo Care AB is developing an innovative medical device – Previct Drugs - a robust, app-based, eHealth-platform for place unbound, continuous, voluntary, self-monitoring of drug use. It will constitute an add-on to Kontigo Care’s current eHealth offer developed for management of other addictive disorders (alcohol abuse and hazard gambling). Using smartphone cameras, patients suffering from drug addiction, will be identified, and asked to record a 10 s long video of their eyes. Analysis of eye biomarkers associated with pharmacodynamically induced pupil reactions (pupillometry) will yield instant results on drug use/sobriety. Our unique, disruptive Internet of Thing (IoT)-based approach is designed to combine continuous monitoring of drug use and daily mood/cravings, with communication tools aimed at improving the impact of distance care. Real-time results become instantly available to caregivers through our cloud-based Care Portal, allowing fast interventions and correct patient prioritisation. This eHealth solution will drive healthcare digitalisation resulting in extreme cost-efficiency of out-patient treatments as well as convenience and complete privacy during drug screenings. A sophisticated AI-system will assess personal risks of relapse and transform addiction management to become proactive instead of reactive. This approach has the potential to enhance personalised therapy outcomes by ensuring that help can be provided fast to the patients who need it the most. The project objective is to prepare for commercialisation of the Previct Drugs module by determining the most efficient routes for gaining clinical and market acceptance by validating the product in clinical settings.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREVICTDRUGS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREVICTDRUGS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More